Future Science Group

sorry, we can't preview this file

Supplementary_data_fo_revised_v4.docx (606.74 kB)

Association between event-free survival and overall survival in early-stage triple-negative breast cancer - supplementary material

Download (606.74 kB)
posted on 2023-08-21, 08:55 authored by Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Wilbur Pan, Vassiliki Karantza, Fan Yang, James Truscott, Yiqiao Xin, Joyce O’Shaughnessy

Table S1. Key characteristics of single-arm trials and cohort studies

Table S2. Base case and sensitivity analyses of individual-level association

Table S3. Predicted results for the trials with immunotherapy using the model without fixed intercept based on non-immunotherapy trials

Table S4. Validation of individual level association

Table S5. Search strategy for the target literature review

Figure S1. PRISMA chart

Figure S2. Trial-level association between EFS and OS excluding immunotherapy trials

Figure S3. Validation of trial-level association


Merck & Co., Inc., (Grant / Award Number)